Clinical trialNCT00614354CompletedPhase 2Interventional

Study of 99mTc-glucarate to Detect Acute Coronary Syndrome in Chest Pain Patients.

SponsorMolecular Targeting Technologies, Inc.Enrollment66Acute Coronary Syndrome

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this clinical trial is to study the ability of a radioactive drug called "Technetium Glucarate" to detect whether the cause of chest pain in patients entering the emergency department with no obvious signs of heart attack is due to a condition called Acute Coronary Syndrome (ACS). The drug will be injected intravenously. After one or two hours the patient will undergo an imaging procedure to detect if the drug has accumulated in the heart. Uptake of the radioactive drug in the heart is indicative of reduced blood flow to the heart.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

Albert J. Sinusas, MD
Yale University
Principal Investigator
clinicaltrials.gov ↗
Ami E Iskandrian, MD
University of Alabama at Birmingham
Principal Investigator
clinicaltrials.gov ↗
Diwakar Jain, MD
Drexel University
Study Chair
clinicaltrials.gov ↗
Prem Soman, MD, Ph.D.
University of Pittsburgh
Principal InvestigatorKOL profile →
clinicaltrials.gov ↗
Robert S Jones, MD
University Hospitals Cleveland Medical Center
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

University of Alabama at Birmingham
Birmingham, Alabama, United States
Yale University
New Haven, Connecticut, United States
University Hospital Case Medical Center
Cleveland, Ohio, United States
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

99mTc-glucarate

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 Oct 2008
Primary completion: 30 Sept 2010
Completion: 30 Sept 2010
Last update posted: 24 Oct 2013
Registered enrollment: 66
Registry id: NCT00614354

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.